离子还原过器的离子还原过器

Marc L Turner¹

¹Edinburgh Blood Transfusion Centre, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK. Marc.Turner@snbts.csa.scot.nhs.uk

Lancet (London, England)

|December 26, 2006

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Cell stem cell·2026

Same author

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Nature medicine·2025

Same author

Harnessing global HLA data for enhanced patient matching in iPSC haplobanks.

Cytotherapy·2024

Same author

The infected blood inquiry report-lessons for gamete donation.

Human fertility (Cambridge, England)·2024

Same author

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation.

Frontiers in immunology·2024

Same author

Long-range inhibition synchronizes and updates prefrontal task activity.

Nature·2023

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

离子还原过器的离子还原过器

相关概念视频

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Harnessing global HLA data for enhanced patient matching in iPSC haplobanks.

The infected blood inquiry report-lessons for gamete donation.

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation.

Long-range inhibition synchronizes and updates prefrontal task activity.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

离子还原过器的离子还原过器

相关概念视频

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Harnessing global HLA data for enhanced patient matching in iPSC haplobanks.

The infected blood inquiry report-lessons for gamete donation.

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation.

Long-range inhibition synchronizes and updates prefrontal task activity.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.